日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Didelphis marsupialis virginiana NADH-ubiquinone oxidoreductase chain 5 (MT-ND5), partial CSB-YP015081DKL
CSB-EP015081DKL
CSB-BP015081DKL
CSB-MP015081DKL
CSB-EP015081DKL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Didelphis marsupialis virginiana ATP synthase protein 8 (MT-ATP8), partial CSB-YP015071DKL1
CSB-EP015071DKL1
CSB-BP015071DKL1
CSB-MP015071DKL1
CSB-EP015071DKL1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lynx lynx Hemoglobin subunit beta (HBB) CSB-YP010150LLA
CSB-EP010150LLA
CSB-BP010150LLA
CSB-MP010150LLA
CSB-EP010150LLA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Eukaryotic translation initiation factor 2 subunit 1 (eIF-2alpha) CSB-YP007523DLU
CSB-EP007523DLU
CSB-BP007523DLU
CSB-MP007523DLU
CSB-EP007523DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Venturia inaequalis Tubulin beta chain CSB-YP025318VEP
CSB-EP025318VEP
CSB-BP025318VEP
CSB-MP025318VEP
CSB-EP025318VEP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Ran GTPase-activating protein 1 (rna1) CSB-YP019318SXV
CSB-EP019318SXV
CSB-BP019318SXV
CSB-MP019318SXV
CSB-EP019318SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cricetulus griseus DNA topoisomerase 2-alpha (TOP2A), partial CSB-YP024060DXU
CSB-EP024060DXU
CSB-BP024060DXU
CSB-MP024060DXU
CSB-EP024060DXU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aedes albopictus 60S ribosomal protein L8 (RpL8) CSB-YP020323AXR
CSB-EP020323AXR
CSB-BP020323AXR
CSB-MP020323AXR
CSB-EP020323AXR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Kluyveromyces marxianus 40S ribosomal protein S6 (RPS6) CSB-YP020463KAN
CSB-EP020463KAN
CSB-BP020463KAN
CSB-MP020463KAN
CSB-EP020463KAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Ribose-phosphate pyrophosphokinase 1 (prs1) CSB-YP018776SXV
CSB-EP018776SXV
CSB-BP018776SXV
CSB-MP018776SXV
CSB-EP018776SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant GTP-binding nuclear protein Ran CSB-YP019307TLU
CSB-EP019307TLU
CSB-BP019307TLU
CSB-MP019307TLU
CSB-EP019307TLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brugia pahangi 40S ribosomal protein S26 CSB-YP020407BWW
CSB-EP020407BWW
CSB-BP020407BWW
CSB-MP020407BWW
CSB-EP020407BWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brugia pahangi Extracellular superoxide dismutase [Cu-Zn] CSB-YP022399BWW
CSB-EP022399BWW
CSB-BP022399BWW
CSB-MP022399BWW
CSB-EP022399BWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida tropicalis V-type proton ATPase subunit B (VMA2), partial CSB-YP002398CZN
CSB-EP002398CZN
CSB-BP002398CZN
CSB-MP002398CZN
CSB-EP002398CZN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus acidocaldarius Elongation factor 2 (fusA), partial CSB-YP007434FOZ
CSB-EP007434FOZ
CSB-BP007434FOZ
CSB-MP007434FOZ
CSB-EP007434FOZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Thymidine kinase (tdk) CSB-YP023577ENV
CSB-EP023577ENV
CSB-BP023577ENV
CSB-MP023577ENV
CSB-EP023577ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cricetulus longicaudatus UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase (DPAGT1), partial CSB-YP007121DXV
CSB-EP007121DXV
CSB-BP007121DXV
CSB-MP007121DXV
CSB-EP007121DXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coturnix coturnix japonica Homeobox protein MSX-2 (MSX2) CSB-YP015069DXJ
CSB-EP015069DXJ
CSB-BP015069DXJ
CSB-MP015069DXJ
CSB-EP015069DXJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lithobates catesbeiana Superoxide dismutase [Cu-Zn] (sod1) CSB-YP022397LQA
CSB-EP022397LQA
CSB-BP022397LQA
CSB-MP022397LQA
CSB-EP022397LQA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neurospora crassa L-amino-acid oxidase (lox), partial CSB-YP011660NHA
CSB-EP011660NHA
CSB-BP011660NHA
CSB-MP011660NHA
CSB-EP011660NHA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×